Effects of Cyclosporin A and Verapamil on Tumor Cells
Author Information
Author(s): H.J. Broxterman, H.M. Pinedo, G.J. Schuurhuis, J. Lankelma
Primary Institution: Free University Hospital
Hypothesis
How do cyclosporin A and verapamil affect energy metabolism and drug accumulation in multidrug-resistant tumor cells?
Conclusion
Cyclosporin A is a more effective inhibitor of daunorubicin transport than verapamil and does not increase energy demand in multidrug-resistant cells.
Supporting Evidence
- Cyclosporin A increased daunorubicin accumulation in resistant cells more than verapamil.
- Verapamil induced a rapid increase in ATP consumption and lactate production in resistant cells.
- Cyclosporin A did not affect the ATP/ADP ratio in resistant cells.
Takeaway
Cyclosporin A helps cancer drugs work better in resistant cells without needing more energy, while verapamil does increase energy use.
Methodology
The study compared the effects of cyclosporin A and verapamil on drug accumulation and energy metabolism in human ovarian carcinoma cells.
Participant Demographics
Human ovarian carcinoma cells (A2780 and 2780AD)
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website